Susan Dorfman's Email & Phone Number

💼 Past Experience

Dr. Dorfman has experience in the Pharmaceuticals Industry. He is currently a President at CMI/Compas. Sr. Strategist at CEGEDIM Dendrite from May 2005 to January 2007 . Sr. Strategist at IMS Health Relationship Management from January 2005 to January 2007 . VP, Sales and Marketing at CCG Marketing Solutions from January 2003 to January 2005 . Account Director - Life Sciences at SBI and Company from January 1999 to January 2001 . Committee Member at IAB Long Tail Alliance Committee from January 2010 to December 2011 . VP - Global Marketing, Product Strategy, and Alliances at Skila from January 2007 to June 2010 . Edison Director Network Member at Edison Ventures Fund. Member of the Editorial Board at Journal of Medical Marketing from February 2010 to November 2018 . Board Member at JoyDew Foundation - from June 2014 to April 2017 . Vice President, Sales and Marketing at Pharmagistics/Reliant from January 2001 to January 2003 . Global Director Professional Services at Qwest Communications from January 1996 to January 1999 . CEO at CMI Media Group. President at CMI Media Group. Management at Amber Heart from January 2001 to January 2005 . Chief Commercial/Growth Officer at CMI Media Group from April 2015 to March 2019 . Chief Marketing, Customer Insights and Innovation Officer at CMI Media Group from June 2010 to April 2015 . Committee Member at mHIMSS and HIMSS Life Sciences Committee/Task Force from December 2011 to January 2013 .

🎓 Education

Dr. Dorfman is a clinical neurologist and professor of neurology and psychiatry at Columbia Business School. Dr. Dorfman has a background in business and economics, having studied at the University of Oxford and New York Institute of Technology. Prior to coming to Columbia Business School, Dr. Dorfman was a associate professor at UoP.

💡 Technical & Interpersonal Skills

Dr. Dorfman's professional, technical, and interpersonal skills are exceptional. Her skills in sales, marketing, and product strategy have led her to success in her current role as President of CMI/Compas. With over 20 years of experience in the Pharmaceuticals industry, she understands the challenging sell-side market conditions and the need for product innovation. In her previous roles, she has been extremely successful in developing and implementing product strategies for both large and small companies, as well as in leading sales and marketing teams. Her interpersonal skills are also highly commendable, as she is highly knowledgeable and dedicated to the development of good relationships with her fellow professionals. Her skills inliaward communication and problem solving are also prized, and she is an excellent team player. As a result, she is an excellent choice for a President of a company with a challenging sell-side market.